Cited by 181Obstructive Sleep Apnea ResearchSleep and related disordersNeuroscience of respiration and sleep

A Controlled Trial of CPAP Therapy on Metabolic Control in Individuals with Impaired Glucose Tolerance and Sleep Apnea

Open access
Weinstock, Tanya G., Wang, Xuelei, Rueschman, Michael, Ismail-Beigi, Faramarz, Aylor, Joan, Babineau, Denise C., Mehra, Reena, Redline, Susan·2012·Sleep

Abstract

STUDY OBJECTIVES: To address whether treatment of sleep apnea improves glucose tolerance. DESIGN: Randomized, double-blind crossover study. SETTING: Sleep clinic referrals. PATIENTS: 50 subjects with moderate to severe sleep apnea (AHI > 15) and impaired glucose tolerance. INTERVENTIONS: Subjects were randomized to 8 weeks of CPAP or sham CPAP, followed by the alternate therapy after a one-month washout. After each treatment, subjects underwent 2-hour OGTT, polysomnography, actigraphy, and measurements of indices of glucose control. MEASUREMENTS AND RESULTS: The primary outcome was normalization of the mean 2-h OGTT; a secondary outcome was improvement in the Insulin Sensitivity Index (ISI (0,120). Subjects were 42% men, mean age of 54 (10), BMI of 39 (8), and AHI of 44 (27). Baseline fasting glucose was 104 (12), and mean 2-h OGTT was 110 (57) mg/dL. Seven subjects normalized their mean 2-h OGTT after CPAP but not after sham CPAP, while 5 subjects normalized after sham CPAP but not after CPAP. Overall, there was no improvement in ISI (0,120) between CPAP and sham CPAP (3.6%; 95% CI: [-2.2%, 9.7%]; P = 0.22). However, in those subjects with baseline AHI ≥ 30 (n = 25), there was a 13.3% (95% CI: [5.2%, 22.1%]; P < 0.001) improvement in ISI (0,120) and a 28.7% (95%CI: [-46.5%, -10.9%], P = 0.002) reduction in the 2-h insulin level after CPAP compared to sham CPAP. CONCLUSIONS: This study did not show that IGT normalizes after CPAP in subjects with moderate sleep apnea and obesity. However, insulin sensitivity improved in those with AHI ≥ 30, suggesting beneficial metabolic effects of CPAP in severe sleep apnea. Clinical trials information: ClinicalTrials.gov Identifier: NCT01385995.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5665/sleep.1816

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 62 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [6]6. Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese non-insulin-dependent diabetic patients: effect of continuous positive air- way pressure treatment on insulin responsiveness. The Journal of clinical endocrinology and metabolism 1994;79:1681-5.

Cited by

Sorted by citations

Authors
Weinstock, T. G., Wang, X., Rueschman, M., Ismail-Beigi, F., Aylor, J., Babineau, D. C., Mehra, R., & Redline, S.
Affiliations
  • Brigham and Women's Hospital (US)
  • Case Western Reserve University (US)
Corresponding author
Redline, Susan
Venue
Sleep
Published
2012-05
Volume
35
Issue
5
Pages
617-625
ISSN
  • 0161-8105 (ISSN-L)
  • 1550-9109
OpenAlex
W2081226646
Cited by
181
References
62
Citations by year
2026: 3 · 2025: 7 · 2024: 4 · 2023: 7 · 2022: 9 · 2021: 7 · 2020: 6 · 2019: 10 · 2018: 20 · 2017: 18 · 2016: 15 · 2015: 29 · 2014: 18 · 2013: 19 · 2012: 7
FWCI
15.66
Type
journal article
Language
en
Open access
Locations
  • SLEEP (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Brigham and Women's Hospital
  • Case Western Reserve University (UL1RR024989)
  • National Institutes of Health (RR024989)
  • National Heart, Lung, and Blood Institute (R01HL075077, HL075077)
  • National Center for Research Resources (UL1RR024989)
Topics
  • Health Sciences › Medicine › Physiology › Obstructive Sleep Apnea Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroscience of respiration and sleep
Keywords
CPAP therapy, sleep apnea, impaired glucose tolerance, insulin sensitivity, insulin resistance, glucose tolerance, apnea-hypopnea index, obesity, metabolic control, sham CPAP
MeSH terms
Blood Glucose, Double-Blind Method, Female, Glucose Tolerance Test, Humans, Male, Middle Aged, Sleep Apnea Syndromes, Polysomnography, Glucose Intolerance, Cross-Over Studies, Continuous Positive Airway Pressure, Actigraphy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review